GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » Intermolecular Inc (NAS:IMI) » Definitions » Enterprise Value

Intermolecular (Intermolecular) Enterprise Value : $59.21 Mil (As of May. 05, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Intermolecular Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Intermolecular's Enterprise Value is $59.21 Mil. Intermolecular's EBIT for the trailing twelve months (TTM) ended in Jun. 2019 was $-11.86 Mil. Therefore, Intermolecular's EV-to-EBIT ratio for today is -4.99.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Intermolecular's Enterprise Value is $59.21 Mil. Intermolecular's EBITDA for the trailing twelve months (TTM) ended in Jun. 2019 was $-7.92 Mil. Therefore, Intermolecular's EV-to-EBITDA ratio for today is -7.47.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Intermolecular's Enterprise Value is $59.21 Mil. Intermolecular's Revenue for the trailing twelve months (TTM) ended in Jun. 2019 was $25.45 Mil. Therefore, Intermolecular's EV-to-Revenue ratio for today is 2.33.


Intermolecular Enterprise Value Historical Data

The historical data trend for Intermolecular's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intermolecular Enterprise Value Chart

Intermolecular Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.83 78.56 21.24 43.76 19.80

Intermolecular Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.05 27.56 19.80 43.87 47.95

Competitive Comparison of Intermolecular's Enterprise Value

For the Semiconductor Equipment & Materials subindustry, Intermolecular's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intermolecular's Enterprise Value Distribution in the Semiconductors Industry

For the Semiconductors industry and Technology sector, Intermolecular's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Intermolecular's Enterprise Value falls into.



Intermolecular Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Intermolecular's Enterprise Value for the fiscal year that ended in Dec. 2018 is calculated as

Intermolecular's Enterprise Value for the quarter that ended in Jun. 2019 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intermolecular  (NAS:IMI) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Intermolecular's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=59.210/-11.857
=-4.99

Intermolecular's current Enterprise Value is $59.21 Mil.
Intermolecular's EBIT for the trailing twelve months (TTM) ended in Jun. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11.86 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Intermolecular's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=59.210/-7.923
=-7.47

Intermolecular's current Enterprise Value is $59.21 Mil.
Intermolecular's EBITDA for the trailing twelve months (TTM) ended in Jun. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.92 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Intermolecular's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=59.210/25.452
=2.33

Intermolecular's current Enterprise Value is $59.21 Mil.
Intermolecular's Revenue for the trailing twelve months (TTM) ended in Jun. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $25.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intermolecular Enterprise Value Related Terms

Thank you for viewing the detailed overview of Intermolecular's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Intermolecular (Intermolecular) Business Description

Traded in Other Exchanges
N/A
Address
3011 North First Street, San Jose, CA, USA, 95134
Intermolecular Inc operates in the technology sector based in the United States. It manufactures and sells support materials for the semiconductor industry. Its HPC platform, which consists of the Tempus processing tools, automated characterization methods and Informatics analysis software, is purpose-built for research and development ("R&D") using combinatorial process systems in concert with established CVD, physical vapor deposition ("PVD") and atomic layer deposition ("ALD") deposition methods. It caters to semiconductor device, semiconductor materials and equipment and clean energy market companies primarily in the Asia-Pacific region.
Executives
Raging Capital Management, Llc 10 percent owner TEN PRINCETON AVENUE, PO BOX 228, ROCKY HILL NJ 08553-0228
Christian Kramer director, officer: President and CEO 6 DAVIS AVE APT B22, RYE NY 10580
Irwin Federman 10 percent owner 2735 SAND HILL ROAD, MENLO PARK CA 94025
Kenneth H Traub director
William C Martin 10 percent owner C/O RAGING CAPITAL MANAGEMENT, LLC, TEN PRINCETON AVENUE, PO BOX 228, ROCKY HILL NJ 08553
Bill Roeschlein officer: Chief Financial Officer C/O SELECTICA, INC., 3 WEST PLUMERIA, SAN JOSE CA 95134
George Scalise director
Marvin D Burkett director C/O ENTEGRIS, INC., 129 CONCORD ROAD, BILLERICA MA 01821
Redpoint Ventures Ii, L.p. 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 290, MENLO PARK CA 94025
Redpoint Associates Ii, Llc 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 290, MENLO PARK CA 94025
Redpoint Ventures Ii, Llc 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 290, MENLO PARK CA 94025
Neil S Subin other: Former 10% Owner 2336 S.E. OCEAN BOULEVARD, #400, STUART FL 34996
Presidio Management Group Ix, L.l.c. 10 percent owner 2735 SAND HILL ROAD, MENLO PARK CA 94025
Steven M Krausz 10 percent owner 2735 SAND HILL ROAD, MENLO PARK CA 94025
U S Venture Partners Ix L P 10 percent owner 2735 SAND HILL RD, MENLO PARK CA 94025

Intermolecular (Intermolecular) Headlines

From GuruFocus